Australia & Optimi Health
2 shared events · Importance 3 · Last updated Jul 02, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Australia: Australia is the recipient country for Optimi Health's psilocybin capsules, providing a regulated market for the treatment of treatment-resistant depression and setting a model for psychedelic medicine use.
Optimi Health: Optimi Health completed its third commercial shipment of psilocybin to Australia, expanding its market presence and generating recurring revenue from the sale of its psychedelic drug products for medical use.
Jun 29, 2026 · 12 articles
Business
Optimi Health: Optimi Health completed the first 2026 production and export of MDMA and psilocybin capsules to Australia, expanding its market access for psychedelic treatments for PTSD and TRD.
Jan 26, 2026 · 6 articles
100
Optimi Health completed export AustraliaOptimi Health Exports...
NEWSDESK
Explore this relationship live
Track how Australia and Optimi Health interact across events, view sentiment trends, and discover connected entities.
Open Dashboard